Navigation Links
UCI awarded $45 million for infectious disease research
Date:5/12/2009

Irvine, Calif., May 12, 2009 The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded UC Irvine $45 million over five years for infectious disease research.

The renewal grant, which is the campus's largest ever, went to the Pacific-Southwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research and its director, Dr. Alan Barbour, a UCI infectious disease expert. Created in May 2005 with a four-year, $40 million NIAID grant, the center and is one of only 11 federally funded research sites dedicated to countering threats from bioterrorism agents and emerging infections.

Pacific-Southwest researchers are located at UCI and 19 other universities and institutes in California, Arizona, Nevada and Hawaii. These include UCLA, USC and the City of Hope.

"Our center brings together some of the region's best scientists to cooperate in research teams. Each person brings a special expertise. Our common goal is prevention and cure of illness by some of the most serious pathogens facing people in the U.S., Latin America and Pacific Rim countries," Barbour said. "We appreciate the new vote of confidence by the National Institutes of Health."

The center's main objective, he said, is to provide the science for creating a defense against emerging diseases, like dengue fever, and potential bioterrorism agents, like the botulism toxin. It also seeks to train next-generation scientists and educate researchers about lab safety.

"While basic research on these infections and immunity to them is at the core of the center, we recognize the importance of the timely translation of our findings into products and other applications that people can actually use," Barbour said. "We've made considerable progress, and we're ready to keep moving ahead."

With the grant, center researchers will continue work on and start new efforts for:

  • Improved protection from and treatment of dengue fever, a mosquito-transmitted viral disease that infects millions worldwide. They also have advanced understanding of why dengue fever can sometimes be fatal, especially among children.

  • Improved detection and treatment of the botulism toxin. Considered one of the most potent, it can contaminate food and cause paralysis and death with only a tiny dose.

  • Improved understanding of and vaccine development for bacterial and viral diseases carried by animals and acquired by humans through either direct contact or an insect or tick. These include tularemia (also known as rabbit fever), Lyme disease, West Nile encephalitis and Lassa fever.

  • Improved detection of and vaccine development for coccidioidomycosis (also known as valley fever), a fungal disease that primarily affects the lungs. It occurs in California and other parts of the southwestern U.S. and in northern Mexico.

"An important part of our work is to find better methods for diagnosing infectious diseases in shorter amounts of time so that appropriate therapy can be started as soon as possible," said UCI's Michael Buchmeier, the center's deputy director. "Our other efforts will focus on new treatments and new vaccines to prevent infections from occurring."


'/>"/>

Contact: Tom Vasich
tmvasich@uci.edu
949-824-6455
University of California - Irvine
Source:Eurekalert

Related biology news :

1. University awarded £1.7M to develop nanotechnology for use in health care
2. LSUHSC student awarded top national honor for diabetes research
3. CSC Awarded $570 Million IT Services Contract by UK Identity and Passport Service
4. Jefferson researcher awarded Landenberger Foundation grant for ALS research
5. CSC Awarded $570 Million IT Services Contract by UK Identity and Passport Service
6. UC and partners awarded $23 million to transform discoveries into real-world health solutions
7. Jonathan Berg, M.D., Ph.D. awarded Richard King Trainee Award for Best in Genetics in Medicine
8. Novocell awarded seminal stem cell patent
9. Fifth annual Templeton-Cambridge fellowships awarded to 10 noted journalists
10. Lehigh researcher awarded $1.8 million NIH grant
11. NYU College of Dentistry awarded $1.9 million NIH grant for HIV research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... 27, 2017   Strategic Cyber Ventures , the ... led a $3.5 million investment in  Polarity , the ... Ventures is DC based and is led by cybersecurity ... . Ron Gula , also a longtime cybersecurity ... in this series A round of funding. This new ...
(Date:2/21/2017)... , February 21, 2017 ... 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr als ... einige Hindernisse zu überwinden gilt, um diese Prognose zu ... ... anderem die Mobilisierung der finanziellen Mittel für die Biobank, ...
(Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... March 23, 2017  SeraCare Life Sciences, ... in vitro diagnostics manufacturers and clinical laboratories, ... first multiplexed Inherited Cancer reference material ... by next-generation sequencing (NGS). The Seraseq™ Inherited Cancer ... input from industry experts to validate the ...
(Date:3/23/2017)... ... March 23, 2017 , ... Ellen ... the Connecticut Technology Council (CTC) as a 2017 Women of Innovation® finalist. Matloff ... of Innovation Awards Dinner. , The dinner recognizes women accomplished in science, technology, ...
(Date:3/23/2017)... 2017 According to a report by Transparency ... fragmented due to the presence of a large pool of participants; ... Fisher , and Sigma-Aldrich, compete with each other in this market. ... more than 76% of this market in 2016.  ... As of now, a large number ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... monitoring solutions, today announced the hire of Dr. Sigmund “Sig” Floyd as Vice ... applications, strategic partnerships and joint development activities. , “Dr. Floyd’s career has spanned ...
Breaking Biology Technology: